Â WASHINGTON_Congress is moving to give federal health officials more money to monitor prescription drug safety, part of an effort to avoid another Vioxx debacle.Â
The House was expected to approve legislation Wednesday that would give the Food and Drug Administration nearly $400 million, collected as fees from the drug industry, to spend on drug safety over the next five years. The Senate has already approved similar legislation.
Both bills also would give the agency more power to require drug companies to do follow-up studies on certain medicines. The House version would require the FDA to periodically review the safety.